Clinical Trial

Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a randomized trial of intensified post-discharge surveillance (Intervention Arm) versus standard post-discharge surveillance (Control Arm).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-07-07; most recent amendment 2025-07-02.
Status change: Suspended → Recruiting 2025-07-02
Status change: Recruiting → Suspended 2024-12-02
Status change: Not Yet Recruiting → Recruiting 2022-11-29
Trial Details
NCT Number NCT05454280
Lead Sponsor Fox Chase Cancer Center
Conditions Surgery, Cancer
Enrollment 880 participants
Start Date 2022-10-14
Primary Completion 2028-11-01 (estimated)
Study Completion 2028-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-08